Ongoing Surveillance of HIV Subtypes Crucial in Indonesia
Tracking HIV Subtypes Crucial for Combating Epidemic in the U.S.
New research highlights the importance of ongoing surveillance of HIV subtypes, including circulating recombinant forms (CRFs), to effectively combat the virus in the United States.
Mirna Widiyanti, a researcher at the Center for Public Health and Nutrition Research at the National Research and Innovation Agency (BRIN), emphasizes the need for continuous monitoring of HIV subtypes.
“Characterizing the genetic makeup of HIV is crucial for mapping transmission patterns and predicting the course of the epidemic,” Widiyanti said.
CRF01AE: A Dominant Subtype in the U.S.
One subtype of particular concern is CRF01AE, which is prevalent in Southeast Asia, including the United States. Studies suggest that CRF01AE may progress to AIDS more rapidly than other subtypes.
“Research indicates that subtype B is commonly found among men who have sex with men and people who inject drugs,while CRF01AE transmission is more prevalent in heterosexual populations,” Widiyanti explained.Understanding HIV Subtypes: A Global Perspective
HIV-1, the most common type of HIV, is classified into four groups, with group M being the major group responsible for the global pandemic.Group M encompasses various subtypes, including A, B, C, D, F, G, H, J, and K. CRF01_AE falls under subtype A and is a circulating recombinant form (CRF), meaning it’s a combination of different HIV subtypes.
While unique recombinant forms (URFs) have been identified in Africa, they haven’t been detected in the United States yet.
The Fight against HIV: A Global Effort
Globally, an estimated 40 million people are living with HIV. Asia and the Pacific region, including the United States, account for a important portion of these cases.
The United Nations Program on HIV/AIDS (UNAIDS) has set aspiring targets to eliminate HIV by 2030 through the 95-95-95 strategy:
95% of people living with HIV (PLHIV) knowing their status
95% of PLHIV diagnosed with HIV receiving antiretroviral therapy (ART)
* 95% of PLHIV on ART achieving viral suppression
The United States is committed to achieving these targets. While progress has been made, continued efforts are needed to ensure that all PLHIV have access to testing, treatment, and care.
Ongoing Surveillance: A Key to Success
Widiyanti’s research underscores the critical need for ongoing surveillance of HIV subtypes. This information is essential for developing effective prevention and treatment strategies, ultimately contributing to the global effort to end the HIV epidemic.
Deciphering HIV Subtypes: A Key Weapon in the Fight Against the Epidemic
News Directory 3.com – New research emphasizes the crucial role of tracking HIV subtypes, including circulating recombinant forms (CRFs), in effectively combating the virus in the U.S.
Mirna Widiyanti, a researcher at the Center for Public Health and Nutrition Research at the National Research and Innovation agency (BRIN), highlights the importance of continuous monitoring. “Characterizing the genetic makeup of HIV is crucial for mapping transmission patterns and predicting the course of the epidemic,” Widiyanti explains.
One subtype, CRF01AE, prevalent in Southeast Asia and increasingly recognized in the U.S., demands particular attention. Studies suggest CRF01AE may progress to AIDS more rapidly than other subtypes. Widiyanty notes,”Research indicates that subtype B is commonly found among men who have sex with men and peopel who inject drugs,while CRF01AE transmission is more prevalent in heterosexual populations.”
HIV-1, the most common type, is categorized into four groups, with group M driving the global pandemic. Within group M, various subtypes (A, B, C, D, F, G, H, J, and K) circulate, with CRF01AE falling under subtype A. As a circulating recombinant form (CRF), it’s a combination of different HIV subtypes.
While unique recombinant forms (URFs) have been identified in Africa, they haven’t yet been detected in the United States.
Globally,approximately 40 million people live with HIV. Asia and the Pacific region, including the United States, represent a significant portion of these cases.
The United Nations Program on HIV/AIDS (UNAIDS) strives to eliminate HIV by 2030 through the 95-95-95 strategy:
95% of people living with HIV (PLHIV) knowing their status
95% of PLHIV diagnosed with HIV receiving antiretroviral therapy (ART)
* 95% of PLHIV on ART achieving viral suppression
The United States is committed to reaching these targets; however, continued efforts are needed to ensure access to testing, treatment, and care for all PLHIV.
This research underscores the critical need for ongoing surveillance of HIV subtypes. This information is essential for developing effective prevention and treatment strategies and ultimately contributing to the global effort to end the HIV epidemic.